to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
Clinical trial NCT03664518 · COMPLETED
Trial details
- NCT number
- NCT03664518
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-04
- Primary completion
- 2022-06-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.